BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7407933)

  • 21. Continuous cell lines with specific killer T-cell activity.
    DiPauli R; Langman R
    Nature; 1979 Jan; 277(5692):134-5. PubMed ID: 310520
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heterogeneity of effectors of normal killer activity against autologous erythrocytes].
    Pukhova IaI; Terskov IA; Kriger NV
    Dokl Akad Nauk SSSR; 1987; 297(2):477-9. PubMed ID: 3428120
    [No Abstract]   [Full Text] [Related]  

  • 23. Enrichment by counterpart centrifugal elutriation of human lymphocytes cytotoxic to human tumour cells.
    Yasaka T; Wells RJ; Mantich NM; Boxer LA; Baehner RL
    Immunology; 1982 Jul; 46(3):613-7. PubMed ID: 7095831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.
    Timonen T; Ortaldo JR; Herberman RB
    J Exp Med; 1981 Mar; 153(3):569-82. PubMed ID: 6166701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte subsets and surface molecules in man.
    Krensky AM; Lanier LL; Engleman EG
    Clin Immunol Rev; 1985; 4(1):95-138. PubMed ID: 2992859
    [No Abstract]   [Full Text] [Related]  

  • 26. Separation and characteristics of tumor-infiltrating lymphocytes in man.
    Klein E; Vánky F; Galili U; Vose BM; Fopp M
    Contemp Top Immunobiol; 1980; 10():79-107. PubMed ID: 6967801
    [No Abstract]   [Full Text] [Related]  

  • 27. Autologous herpes simplex virus-infected cells are lysed by human natural killer cells.
    Yasukawa M; Zarling JM
    J Immunol; 1983 Oct; 131(4):2011-6. PubMed ID: 6311903
    [No Abstract]   [Full Text] [Related]  

  • 28. Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer cells.
    Itoh K; Platsoucas CD; Tilden AB; Pollock RE; Balch CM
    Cell Immunol; 1987 Sep; 108(2):283-96. PubMed ID: 3113741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.
    Zarling JM; Eskra L; Borden EC; Horoszewicz J; Carter WA
    J Immunol; 1979 Jul; 123(1):63-70. PubMed ID: 286738
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphocyte subsets, natural killer cytotoxicity, and perioperative blood transfusion for elective colorectal cancer surgery.
    Tartter PI; Martinelli G
    Cancer Detect Prev Suppl; 1987; 1():571-6. PubMed ID: 3480069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning of human CD3+ T cells and CD3- natural killer cells and requirements for long-term expansion.
    van de Griend RJ; Goedegebuure SP; van Krimpen BA; Bolhuis RL
    Transplant Proc; 1988 Apr; 20(2):149-54. PubMed ID: 2966464
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of natural killer activity and antibody-dependent cellular cytotoxicity by cultured human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1981 Jun; 126(6):2221-9. PubMed ID: 6453160
    [No Abstract]   [Full Text] [Related]  

  • 33. Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets.
    Yasaka T; Mantich NM; Boxer LA; Baehner RL
    J Immunol; 1981 Oct; 127(4):1515-8. PubMed ID: 6268707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities.
    Kumagai K; Itoh K; Suzuki R; Hinuma S; Saitoh F
    J Immunol; 1982 Jul; 129(1):388-94. PubMed ID: 6979572
    [No Abstract]   [Full Text] [Related]  

  • 35. Natural killer (NK) activity of normal human peripheral blood lymphocytes against erythroleukemic cell line K 562.
    Tanaka Y
    Hiroshima J Med Sci; 1981 Jun; 30(2):115-26. PubMed ID: 6946049
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison between the in vitro interaction of lectins (PHA and con A) and antimicrococcus antibodies on normal and malignant cells.
    Verloes R; Atassi G; Kanarek L
    Eur J Cancer (1965); 1979 Dec; 15(12):1439-48. PubMed ID: 535606
    [No Abstract]   [Full Text] [Related]  

  • 37. T-cell-mediated cytotoxicity in patients with colorectal cancer.
    Klajman A; Farkas R; Drucker I; Schneider M; Becker M; Man B; Reiss R
    Clin Immunol Immunopathol; 1980 Nov; 17(3):335-43. PubMed ID: 6968644
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells.
    Le Gros GS; Herbert AG; Watson JD
    Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The functional dissection of human peripheral null cells with respect to antibody-dependent cellular cytotoxicity and natural killing.
    Ozer H; Strelkauskas AJ; Callery RT; Schlossman SF
    Eur J Immunol; 1979 Feb; 9(2):112-8. PubMed ID: 312204
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.
    Eremin O; Coombs RR; Ashby J
    Br J Cancer; 1981 Aug; 44(2):166-76. PubMed ID: 6268135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.